Starpharma Holdings Ltd (SPHRF)
0.0774
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Starpharma Holdings Total Liabilities (Quarterly): 6.459M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 6.459M |
June 30, 2023 | 11.43M |
December 31, 2022 | 11.31M |
June 30, 2022 | 12.23M |
December 31, 2021 | 8.876M |
June 30, 2021 | 8.218M |
December 31, 2020 | 6.328M |
June 30, 2020 | 5.327M |
December 31, 2019 | 6.014M |
June 30, 2019 | 4.527M |
December 31, 2018 | 3.024M |
June 30, 2018 | 3.845M |
December 31, 2017 | 3.846M |
June 30, 2017 | 4.309M |
December 31, 2016 | 3.844M |
June 30, 2016 | 7.180M |
December 31, 2015 | 5.067M |
June 30, 2015 | 5.235M |
December 31, 2014 | 3.351M |
June 30, 2014 | 3.682M |
December 31, 2013 | 2.932M |
June 30, 2013 | 2.396M |
December 31, 2012 | 3.272M |
Date | Value |
---|---|
June 30, 2012 | 5.635M |
December 31, 2011 | 2.422M |
June 30, 2011 | 2.259M |
December 31, 2010 | 2.288M |
June 30, 2010 | 2.29M |
December 31, 2009 | 1.90M |
June 30, 2009 | 2.698M |
December 31, 2008 | 3.094M |
June 30, 2008 | 4.089M |
December 31, 2007 | 3.569M |
June 30, 2007 | 3.984M |
December 31, 2006 | 5.528M |
December 31, 2005 | 2.718M |
June 30, 2005 | 1.930M |
December 31, 2004 | 1.230M |
June 30, 2004 | 0.626M |
December 31, 2003 | 0.617M |
June 30, 2003 | 0.9907M |
December 31, 2002 | 0.4664M |
June 30, 2002 | 0.8969M |
December 31, 2001 | 0.3963M |
June 30, 2001 | 0.5663M |
December 31, 2000 | 0.2228M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.527M
Minimum
Jun 2019
12.23M
Maximum
Jun 2022
8.072M
Average
7.339M
Median
Total Liabilities (Quarterly) Benchmarks
Alterity Therapeutics Ltd | 2.345M |
Kazia Therapeutics Ltd | 13.02M |
Immutep Ltd | 9.137M |
Opthea Ltd | 213.41M |
Mesoblast Ltd | 167.58M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 29.93M |
Shareholders Equity (Quarterly) | 23.47M |
Debt to Equity Ratio | 0.0908 |
Current Ratio | 5.604 |
Net Debt Paydown Yield | 0.46% |